| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |